SC 13D/A 1 c31443-sc13da.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2) THE KOREA FUND, INC. -------------------- (Name of Issuer) COMMON STOCK ------------ (Title of Class of Securities) 500634100 --------- (CUSIP Number) Michael Pradko Harvard Management Company, Inc. 600 Atlantic Avenue Boston, Massachusetts 02210 (617) 523-4400 with a copy to: THEODORE ALTMAN, ESQ. PIPER RUDNICK LLP 1251 AVENUE OF THE AMERICAS NEW YORK, NEW YORK 10020-1104 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) MARCH 15, 2004 -------------- (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] Page 1 of 4 Pages
-------------------------------- --------------------------------- CUSIP No. 500634100 SCHEDULE 13D AMENDMENT NO. 2 Page 2 of 4 Pages -------------------------------- --------------------------------- ------------- ----------------------------------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NUMBERS President and Fellows of Harvard College ------------- ----------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| ------------- ----------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY ------------- ----------------------------------------------------------------------------------------------------------- 4 SOURCE OF FUNDS WC ------------- ----------------------------------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_| ------------- ----------------------------------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Massachusetts ------------------------------------ --------- -------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER BENEFICIALLY 11,813,400 OWNED BY EACH --------- -------------------------------------------------------------------------- REPORTING PERSON 8 SHARED VOTING POWER WITH 0 --------- -------------------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER 11,813,400 --------- -------------------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 ------------- ----------------------------------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11,813,400 ------------- ----------------------------------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |_| ------------- ----------------------------------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 23.75% ------------- ----------------------------------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON EP ------------- -----------------------------------------------------------------------------------------------------------
This second amendment (the "Second Amendment") amends and supplements the statement on Schedule 13D, as amended by Amendment No. 1 (the "Schedule"), previously filed with the Securities and Exchange Commission on December 15, 2003 by the President and Fellows of Harvard College ("Harvard"), with respect to the common stock, par value $0.01 per share (the "Common Stock"), of The Korea Fund, a Maryland corporation (the "Issuer"). ITEM 4. PURPOSE OF TRANSACTION. On March 15, 2004 Harvard sent a letter to each of the Independent Directors of the Issuer. The letter stated Harvard's position that the actions taken by the Issuer to address the discount to net asset value have been inadequate, offered to separately discuss its concerns with the Independent Directors and stated that if it concluded that the interest of the investment manager is unduly persuading the Board, it will seriously consider taking steps necessary to remove that influence. The full text of the letter is set forth as Exhibit 99.1 hereto. Except as described above, Harvard does not have any plans or proposals which relate to or would result in any of the actions set forth in parts (a) through (j) of Item 4. Harvard reserves the right to make any such plans or proposals in the future or to take any other steps to enhance the value of its investment. ITEM 7. MATERIALS TO BE FILED AS EXHIBITS. The following document is filed as an Exhibit to this Second Amendment: EXHIBIT 99.1: Letter, dated March 15, 2004. Page 3 of 4 Pages SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: March 15, 2004 PRESIDENT AND FELLOWS OF HARVARD COLLEGE By: /s/ Michael S. Pradko ------------------------------------- Name: Michael S. Pradko Title: Authorized Signatory Page 4 of 4 Pages